Furthermore, analysis of two independent breast cancer patient data sets (Curtis and Ivshina)38,39 showed that MELK expression is elevated at mRNA levels in p53-mutant breast cancer tumors (Fig. 1b) and the elevation of MELK expression is independent of ER status (Supplementary Fig. 2B). The gene discussed is TP53; the disease is breast carcinoma.